Endothelium removal augments endothelium-independent vasodilatation in rat mesenteric vascular bed

British Journal of Pharmacology

Volumn 154, Issue 1, 2008, Pages 32-40

  Iwatani, Y ^a   Kosugi, K ^a   Isobe Oku, S ^a   Atagi, S ^a   Kitamura, Y ^a   Kawasaki, H ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Calcitonin gene related peptide; Endothelium derived contracting factor; Endothelium derived relaxing factor; Isoprenaline; Periarterial nerve stimulation; Sodium nitroprusside; Vascular endothelium removal; Vasodilatation

Indexed keywords

4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 8 BROMO CYCLIC GMP; CALCITONIN GENE RELATED PEPTIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DEOXYCHOLATE SODIUM; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; INDOMETACIN; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; PHOSPHORAMIDON; SERATRODAST; VASOACTIVE AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MESENTERY BLOOD FLOW; NERVE STIMULATION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; VASCULAR ENDOTHELIUM; VASODILATATION; WISTAR RAT;

EID: 42949142058     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.72     Document Type: Article

References (26)

1. Bevan JA, Brayden JE (1987). Nonadrenergic neural vasodilator mechanisms. Circ Res 60: 309–326.
2. Burnstock G, Ralevic V (1994). New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plast Surg 47: 527–543.
3. Dhanakoti SN, Gao Y, Nguyen MQ, Raj JU (2000). Involvement of cGMP‐dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol 88: 1637–1642.
4. Dora KA, Hinton JM, Walker SD, Garland CJ (2000). An indirect influence of phenylephrine on the release of endothelium‐derived vasodilations in rat small mesenteric artery. Br J Pharmacol 129: 381–387.
5. Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H et al. (2006). Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 17: 286–295.
6. Furchgott RF, Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376.
7. Grace GC, Macdonald PS, Dusting GT (1988). Cyclic nucleotide interactions involved in endothelium‐dependent dilatation in rat aortic rings. Eur J Pharmacol 148: 17–24.
8. Han SP, Naes L, Westfall TC (1990). Inhibition of periarterial nerve stimulation‐induced vasodilation of the mesenteric arterial bed by CGRP (8–37) and CGRP receptor desensitization. Biochem Biophys Res Commun 168: 786–791.
9. Husain M, Moss J (1988). Endothelium‐dependent vascular smooth muscle control. J Clin Anesth 1: 135–145.
10. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S et al. (1992). Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50: 247–255.
11. Kawasaki H, Nuki C, Saito A, Takasaki K (1991). NPY modulates neurotransmission of CGRP‐containing vasodilator nerves in rat mesenteric arteries. Am J Physiol 261: H683–H690.
12. Kawasaki H, Takasaki K, Saito A, Goto K (1988). Calcitonin gene‐related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335: 54–56.
13. Kubota M, Moseley JM, Butera L, Dustung GJ, Macdonald PS, Martin TJ (1985). Calcitonin gene‐related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun 132: 88–94.
14. Lundberg MJ, Terenius L, Hokfelt T, Martling RC, Tatemoto K, Mutt V et al. (1982). Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116: 477–480.
15. Matsumura Y, Hisaki K, Takaoka M, Morimoto S (1990). Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin‐1. Eur J Pharmacol 185: 103–106.
16. Moncada S, Palmer RM, Higgs EA (1991a). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142.
17. Moncada S, Ress DD, Schulz R, Palmer RM (1991b). Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88: 2166–2170.
18. Priviero FB, Baracat JS, Teixeira CE, Claudino MA, De Nucci G, Antunes E (2005). Mechanisms underlying relaxation of rabbit aorta by BAY 41‐2272, a nitric oxide‐independent soluble guanylate cyclase activator. Clin Exp Pharmacol Physiol 32: 728–734.
19. Ralevic V (2002). Endothelial nitric oxide modulates perivascular sensory neurotransmission in rat isolated mesenteric arterial bed. Br J Pharmacol 137: 19–28.
20. Ralevic V, Burnstock G (1991). Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res 69: 1583–1590.
21. Ress SR, Ratanjee B, Meyers OL, Keraan M (1986). Laboratory assessment of immune status: uses and limitations. Br J Clin Pract 40: 288–291.
22. Stasch JP, Becker EM, Alonso‐Alija C, Apeler H, Dembowsky K, Feurer A et al. (2001). NO‐independent regulatory site on soluble guanylate cyclase. Nature 410: 212–215.
23. Takenaga M, Kawasaki H, Wada A, Eto T (1995). Calcitonin gene‐related peptide mediates acetylcholine‐induced endothelium‐independent vasodilation in mesenteric resistance blood vessels of the rat. Circ Res 76: 935–941.
24. Urabe M, Kawasaki H, Takasaki K (1991). Effect of endothelium removal on the vasoconstrictor response to neuronally released 5‐hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries. Br J Pharmacol 102: 85–90.
25. Vanhoutte PM, Mombouli JV (1996). Vascular endothelium: vasoactive mediators. Prog Cardiovasc Dis 1119: 229–238.
26. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, DeWit D et al. (1994). ECE‐1: a membrane‐bound metalloprotease that catalyzes the proteolytic activation of big endothelin‐1. Cell 78: 473–485.